Targeting SAMHD1 Promotes Anti-Tumor Immunity in Acute Myeloid Leukemia

被引：1
|
作者：
Zhang, Lei [1 ]
Dong, Haojie [2 ]
He, Xin [1 ]
Lin, Yichun [3 ]
Hu, Weidong [4 ]
Salhotra, Amandeep [5 ]
Armenian, Saro H. [6 ]
Marcucci, Guido [5 ,7 ]
Luo, Yun [8 ]
Li, Ling [9 ]
机构：
[1] City Hope Natl Med Ctr, Gehr Family Ctr Leukemia Res, Hematol Malignancies & Stem Cell Transplantat Ins, Beckman Res Inst,Dept Hematol Malignancies Transl, Monrovia, CA USA
[2] City Hope Natl Med Ctr, Gehr Family Ctr Leukemia Res, Hematol Malignancies & Stem Cell Transplantat Ins, Beckman Res Inst,Dept Hematol Malignancies Transl, Duarte, CA USA
[3] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA
[4] City Hope Natl Med Ctr, Dept Immunol & Theranost, Duarte, CA USA
[5] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[6] City Hope Natl Med Ctr, Dept Pediat, Duarte, CA USA
[7] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[8] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA USA
[9] City Hope Natl Med Ctr, Hematol Malignancies & Stem Cell Transplantat Ins, Gehr Family Ctr Leukemia Res,Dept Pediat, Beckman Res Inst,Dept Hematol Malignancies Transl, Duarte, CA USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-167653
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Targeting the myeloid-cell specific SRC-kinase HCK improves anti-tumor immunity
    Ernst, Matthias R.
    Chand, Ashwini
    Huntington, Nicholas
    O'Donoghue, Robert
    Poh, Ashleigh
    CANCER RESEARCH, 2019, 79 (13)
  • [42] ANTIBODY BLOCKADE OF THE IMMUNOINHIBITORY RECEPTOR SIGLEC 10 POLARIZES TUMOR ASSOCIATED MYELOID CELLS AND PROMOTES ANTI-TUMOR IMMUNITY
    Schanin, Julia
    Luu, Thuy
    Sanchez, Robert
    Peterson, Milene
    McEwan, Lisa
    Henneberry, Evan
    Chang, Katherine
    Korver, Wouter
    Leung, John
    Youngblood, Bradford
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1451 - A1451
  • [43] Targeting of the innate immunity/inflammation as complementary anti-tumor therapies
    Germano, Giovanni
    Mantovani, Alberto
    Allavena, Paola
    ANNALS OF MEDICINE, 2011, 43 (08) : 581 - 593
  • [44] Targeting CSK kinase activity to enhance anti-tumor immunity
    Wang, Cindy
    Cao, Carolyn
    Berman-Booty, Lisa
    Swanson, Jesse
    Eraslan, Rukiye
    Sanjuan, Miguel
    Vite, Gregory
    Qin, Lan-Ying
    Hunt, John
    Fink, Bryan
    Wee, Susan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [45] Pharmacological strategies to overcome treatment resistance in acute myeloid leukemia: increasing leukemic drug exposure by targeting the resistance factor SAMHD1 and the toxicity factor Top2β
    Herold, Nikolas
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (01) : 7 - 11
  • [46] Downregulation of the Tumor Suppressor SAMHD1 in Classical Hodgkin Lymphoma
    Xagoraris, Ioanna
    Vassilakopoulos, Theodoros
    Herold, Nikolas
    Tsesmetzis, Nikolaos
    Drakos, Elias
    Khoury, Joseph David
    Rassidakis, George
    BLOOD, 2017, 130
  • [47] Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity
    Natoli, Marina
    Herzig, Petra
    Pishali Bejestani, Elham
    Buchi, Melanie
    Ritschard, Reto
    Lloyd, G. Kenneth
    Mohanlal, Ramon
    Tonra, James R.
    Huang, Lan
    Heinzelmann, Viola
    Trub, Marta
    Zippelius, Alfred
    Kashyap, Abhishek S.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [48] Targeting ENPP1 to boost anti-tumor immunity during PARP inhibition
    Li, Jie
    Mason, Charlotte
    Hanggi, Kay
    Luca, Vincent
    Ruffell, Brian
    CANCER RESEARCH, 2023, 83 (07)
  • [49] SAMHD1: a restriction factor in the replication of HIV-1 in myeloid cells
    Guenzel, Caroline A.
    Benichou, Serge
    VIROLOGIE, 2011, 15 (05) : 338 - 340
  • [50] SAMHD1: a new insight into HIV-1 restriction in myeloid cells
    Corine St Gelais
    Li Wu
    Retrovirology, 8
12345